Item 16. Form 10-K Summary
28K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
Not applicable
Exhibit Index
(Note: Exhibits 10.3 through 10.25 and 10.27 through 10.30 are management contracts or compensatory plans or arrangements required to be filed as an exhibit to this Report pursuant to Item 15(b) of this Report. References herein to “AMVESCAP,” or “AMVESCAP PLC” are to the predecessor registrant to Invesco Ltd.)
| 31.1 | Certification of Martin L. Flanagan pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||||
| 31.2 | Certification of L. Allison Dukes pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||||
| 32.1 | Certification of Martin L. Flanagan pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||||
| 32.2 | Certification of L. Allison Dukes pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||||
| 101 | The following financial statements from the Company’s Quarterly Report on Form 10-K for the year ended December 31, 2021, formatted in Inline XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Cash Flows, (v) Consolidated Statements of Changes in Equity, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags. | ||||
| 104 | The cover page from the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, formatted in Inline XBRL |
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Invesco Ltd. | |||||
| By: | /s/ MARTIN L. FLANAGAN | ||||
| Name: | Martin L. Flanagan | ||||
| Title: | President and Chief Executive Officer | ||||
| Date: | February 18, 2022 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities indicated and on the dates indicated.
| Name | Title | Date | ||||||
| /s/ MARTIN L. FLANAGAN | Chief Executive Officer (Principal Executive Officer) and President; Director | February 18, 2022 | ||||||
| Martin L. Flanagan | ||||||||
| /s/ L. ALLISON DUKES | Senior Managing Director and Chief Financial Officer (Principal Financial Officer) | February 18, 2022 | ||||||
| L. Allison Dukes | ||||||||
| /s/ ANNETTE LEGE | Chief Accounting Officer (Principal Accounting Officer) | February 18, 2022 | ||||||
| Annette Lege | ||||||||
| /s/ G. RICHARD WAGONER, JR. | Chairperson and Director | February 18, 2022 | ||||||
| G. Richard Wagoner, Jr. | ||||||||
| /s/ SARAH E. BESHAR | Director | February 18, 2022 | ||||||
| Sarah E. Beshar | ||||||||
| /s/ THOMAS M. FINKE | Director | February 18, 2022 | ||||||
| Thomas M. Finke | ||||||||
| /s/ WILLIAM F. GLAVIN, JR. | Director | February 18, 2022 | ||||||
| William F. Glavin, Jr. | ||||||||
| /s/ C. ROBERT HENRIKSON | Director | February 18, 2022 | ||||||
| C. Robert Henrikson | ||||||||
| /s/ DENIS KESSLER | Director | February 18, 2022 | ||||||
| Denis Kessler | ||||||||
| /s/ SIR NIGEL SHEINWALD | Director | February 18, 2022 | ||||||
| Sir Nigel Sheinwald | ||||||||
| /s/ PAULA C. TOLLIVER | Director | February 18, 2022 | ||||||
| Paula C. Tolliver | ||||||||
| /s/ CHRISTOPHER C. WOMACK | Director | February 18, 2022 | ||||||
| Christopher C. Womack | ||||||||
| /s/ PHOEBE A. WOOD | Director | February 18, 2022 | ||||||
| Phoebe A. Wood |
Previous: Item 15. Exhibits and Financial Statement Schedule